Cancer is a spectrum of diseases whose control will ultimately require a basic understanding of the events that permit cells to begin to divide in an uncontrolled manner and subsequently invade normal tissue. Bacterial and fungal opportunistic infections have emerged as major causes of morbidity and mortality in immunocompromised patients, particularly those undergoing high dose chemotherapy for the treatment of solid tumors, or prolonged treatment for leukemia, lymphoma and other cancer-related hematologic disorders. The objectives of the proposed training program will be to direct predoctoral students in basic research on multi-disciplinary aspects of carcinogenesis and pathogenesis. The major goal is to train young scientists who will continue their careers in cancer biology and host-pathogen interactions, and subsequently make an impact on their specific area of research interest. The faculty participants in this program represent the medical school's most competitive scientists with interest in carcinogenesis and pathogenesis, and are drawn from the Departments of Pathology, Biochemistry and Molecular Biology, Physiology and Molecular Medicine, Medicine, and Microbiology and Immunology. The faculty participants include Drs. M. You (molecular genetics of lung cancer), J.C. Willey (carcinogens implicated in lung cancer), R. Ruch (cell-cell communication), J.P. Trempe (gene therapy of cancer), M. Ratnam (novel chemotherapeutic approaches to cancer), L. Faber (progestins, immunosuppressants and breast cancer), M. Pereira (prevention of colorectal carcinoma), D.L. Sawicki (regulation of viral replication), M. Boyle (plasminogen activation and bacterial pathogenesis. G.T. Cole (immunomodulation related to opportunistic fungal invasion), and D.W. Metzgar (cytokine regulation of immunity). All predoctoral students will matriculate through the existing Medical College of Ohio's Medical Sciences Program in either the Molecular Basis of Disease or Molecular and Cellular Biology areas of programmatic concentration. In addition to the requirements of the programmatic concentration, students in this training program, called Molecular Pathogenesis of Cancer (MPC) will be required to take 2 cancer-oriented courses and participate in training program activities (seminar series, journal club, research conferences and research retreats).

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA079450-03
Application #
6350324
Study Section
Subcommittee G - Education (NCI)
Project Start
1999-04-06
Project End
2004-01-31
Budget Start
2001-02-01
Budget End
2002-01-31
Support Year
3
Fiscal Year
2001
Total Cost
$120,287
Indirect Cost
Name
University of Toledo
Department
Biochemistry
Type
Schools of Medicine
DUNS #
807418939
City
Toledo
State
OH
Country
United States
Zip Code
43614
Rosati, Rayna; Chen, Bailing; Patki, Mugdha et al. (2016) Hybrid Enzalutamide Derivatives with Histone Deacetylase Inhibitor Activity Decrease Heat Shock Protein 90 and Androgen Receptor Levels and Inhibit Viability in Enzalutamide-Resistant C4-2 Prostate Cancer Cells. Mol Pharmacol 90:225-37
Sterling, Julie A; Wu, Liang; Banerji, Sunandita S (2006) PARP regulates TGF-beta receptor type II expression in estrogen receptor-positive breast cancer cell lines. Anticancer Res 26:1893-901
McCabe, N Patrick; Selman, Steven H; Jankun, Jerzy (2006) Vascular endothelial growth factor production in human prostate cancer cells is stimulated by overexpression of platelet 12-lipoxygenase. Prostate 66:779-87
Miocinovic, Ranko; McCabe, N Patrick; Keck, Rick W et al. (2005) In vivo and in vitro effect of baicalein on human prostate cancer cells. Int J Oncol 26:241-6
Skrzypczak-Jankun, E; Borbulevych, O Y; Melillo, A et al. (2005) Aspirin blocks binding of photosensitizer SnET2 into human serum albumin: implications for photodynamic therapy. Int J Mol Med 15:777-83
Tran, Thuyet; Shatnawi, Aymen; Zheng, Xuan et al. (2005) Enhancement of folate receptor alpha expression in tumor cells through the glucocorticoid receptor: a promising means to improved tumor detection and targeting. Cancer Res 65:4431-41
Kelley, Karen M M; Rowan, Brian G; Ratnam, Manohar (2003) Modulation of the folate receptor alpha gene by the estrogen receptor: mechanism and implications in tumor targeting. Cancer Res 63:2820-8
Northcott, Carrie A; Poy, Matthew N; Najjar, Sonia M et al. (2002) Phosphoinositide 3-kinase mediates enhanced spontaneous and agonist-induced contraction in aorta of deoxycorticosterone acetate-salt hypertensive rats. Circ Res 91:360-9
Salmon, M L; Madanagopal, S G; Blando, R et al. (2002) Effects of hexachlorobenzene on embryonic mammalian cells. Toxicol In Vitro 16:539-48
Poy, Matthew N; Ruch, Randall J; Fernstrom, Mats A et al. (2002) Shc and CEACAM1 interact to regulate the mitogenic action of insulin. J Biol Chem 277:1076-84